In HCC, KANK2 expression was found to be positively correlated with these immune checkpoint markers, indicating that KANK2 may contribute to the formation of an immunosuppressive environment, which could influence the effectiveness of immunotherapy. Here, KANK2 is linked to hepatocellular carcinoma.